PASG earnings: next report 2026-08-11, real EPS beat/miss history, analyst consensus Buy, P/E -0.42. Updated 2026-07-23.
Passage Bio (PASG) Research Hub
Passage Bio (PASG) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 5 USD (+1.21%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.42, market cap 0.02B. This hub links to the full technical, earnings and options research available for PASG.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 5 USD (+1.21%) |
| 52-week range | 4.19 USD – 6.3 USD |
| Trend regime | Range |
| 14-day RSI | 65.8 (Bullish) |
| Trailing P/E | -0.42 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for PASG
Covered Call on PASG: how it works, illustrative setup around the real 5 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PASG: how it works, illustrative setup around the real 5 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PASG: how it works, illustrative setup around the real 5 USD price, max profit/loss, breakeven and when to use it. Educational.
PASG technical analysis: range, last 5 USD, RSI 65.8, 52w range 4.19 USD–6.3 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is PASG in?
Passage Bio (PASG) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is PASG in an uptrend or downtrend?
As of 2026-09-11, PASG is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PASG's trailing P/E ratio?
PASG's trailing P/E is -0.42, with a market cap of 0.02B. See the earnings research page for full valuation detail.
When does PASG next report earnings?
PASG is next scheduled to report earnings on 2026-08-11, with a consensus EPS estimate of -2.64667 USD.